2012 annual financial data
Anika Therapeutics 2012 Net margin
Anika Therapeutics 2012 net margin with verified reported values.
Direct answer
Net margin was 16.48%.
Operating income was 19,715,198 USD and net income was 11,757,460 USD.
Operating cash flow was 10,548,677 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 71,358,505 USD
- Operating income
- 19,715,198 USD
- Net income
- 11,757,460 USD
- Operating cash flow
- 10,548,677 USD